Thus, even a short iRGD-induced spike in AFP transport from the tumour would be expected to cause elevated blood AFP levels for at least several hours, rendering it suitable to detect a potential iRGD-induced tumour-to-blood transport. The gene discussed is AFP; the disease is neoplasm.